Inhibition of nitric oxide synthesis enhances insulin-hypertension in conscious rats

B. W. Shek, H. L. Keen, Michael W Brands, J. E. Hall

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We have previously shown that chronic hypcrinsulinemia causes hypertension in rats and acute studies suggest that endothelial-derived nitric oxide (EDNO) may modulate the vascular actions of insulin. The present study was designed to determine whether blockade of EDNO synthesis with nitro-L-arginine methyl ester (L-NAME) exacerbates the hypertensive actions of insulin in conscious rats. Male Sprague-Dawley rats were instrumented with arterial and venous catheters and mean arterial pressure (MAP) was monitored continuously 24 hr/day. After 7 days of control measurments, rats were given either vehicle (C rats, n=4) or L-NAME (10 μg/kg/min, i.V., n=4) throughout the entire experiment After 4 days of L-NAME or vehicle infusion, a 5 day infusion of insulin (1.5 mU/kg/min, i.v.) was initiated while euglycemia was maintained with glucose infusion (22 mg/kg/min, i.v.). After 4 days of L-NAME infusion, MAP increased from 91±1 to 122±2 mmHg. Vehicle infusion did not significantly alter MAP in C rats. After 5 days of insulin infusion, MAP increased to a greater extent in L-NAME rats than in C rats (21±4 vs 8±0.3 mmHg). Thus, blockade of EDNO synthesis significantly enhanced the chronic hypertensive effects of insulin in rats. These observations suggest that EDNO may help to minimize the rise in blood pressure during chronic hyperinsulinemia in rats. (Supported by HL51971, HL39399, and HL23502).

Original languageEnglish (US)
JournalFASEB Journal
Volume10
Issue number3
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

hypertension
nitric oxide
Rats
Nitric Oxide
insulin
Insulin
Hypertension
NG-Nitroarginine Methyl Ester
synthesis
rats
Arterial Pressure
Rat control
Arginine
Catheters
Blood pressure
Hyperinsulinism
hyperinsulinemia
Blood Vessels
Sprague Dawley Rats
blood vessels

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Inhibition of nitric oxide synthesis enhances insulin-hypertension in conscious rats. / Shek, B. W.; Keen, H. L.; Brands, Michael W; Hall, J. E.

In: FASEB Journal, Vol. 10, No. 3, 01.12.1996.

Research output: Contribution to journalArticle

@article{0717ce70bba3492d9e5246ff01af71d2,
title = "Inhibition of nitric oxide synthesis enhances insulin-hypertension in conscious rats",
abstract = "We have previously shown that chronic hypcrinsulinemia causes hypertension in rats and acute studies suggest that endothelial-derived nitric oxide (EDNO) may modulate the vascular actions of insulin. The present study was designed to determine whether blockade of EDNO synthesis with nitro-L-arginine methyl ester (L-NAME) exacerbates the hypertensive actions of insulin in conscious rats. Male Sprague-Dawley rats were instrumented with arterial and venous catheters and mean arterial pressure (MAP) was monitored continuously 24 hr/day. After 7 days of control measurments, rats were given either vehicle (C rats, n=4) or L-NAME (10 μg/kg/min, i.V., n=4) throughout the entire experiment After 4 days of L-NAME or vehicle infusion, a 5 day infusion of insulin (1.5 mU/kg/min, i.v.) was initiated while euglycemia was maintained with glucose infusion (22 mg/kg/min, i.v.). After 4 days of L-NAME infusion, MAP increased from 91±1 to 122±2 mmHg. Vehicle infusion did not significantly alter MAP in C rats. After 5 days of insulin infusion, MAP increased to a greater extent in L-NAME rats than in C rats (21±4 vs 8±0.3 mmHg). Thus, blockade of EDNO synthesis significantly enhanced the chronic hypertensive effects of insulin in rats. These observations suggest that EDNO may help to minimize the rise in blood pressure during chronic hyperinsulinemia in rats. (Supported by HL51971, HL39399, and HL23502).",
author = "Shek, {B. W.} and Keen, {H. L.} and Brands, {Michael W} and Hall, {J. E.}",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Inhibition of nitric oxide synthesis enhances insulin-hypertension in conscious rats

AU - Shek, B. W.

AU - Keen, H. L.

AU - Brands, Michael W

AU - Hall, J. E.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - We have previously shown that chronic hypcrinsulinemia causes hypertension in rats and acute studies suggest that endothelial-derived nitric oxide (EDNO) may modulate the vascular actions of insulin. The present study was designed to determine whether blockade of EDNO synthesis with nitro-L-arginine methyl ester (L-NAME) exacerbates the hypertensive actions of insulin in conscious rats. Male Sprague-Dawley rats were instrumented with arterial and venous catheters and mean arterial pressure (MAP) was monitored continuously 24 hr/day. After 7 days of control measurments, rats were given either vehicle (C rats, n=4) or L-NAME (10 μg/kg/min, i.V., n=4) throughout the entire experiment After 4 days of L-NAME or vehicle infusion, a 5 day infusion of insulin (1.5 mU/kg/min, i.v.) was initiated while euglycemia was maintained with glucose infusion (22 mg/kg/min, i.v.). After 4 days of L-NAME infusion, MAP increased from 91±1 to 122±2 mmHg. Vehicle infusion did not significantly alter MAP in C rats. After 5 days of insulin infusion, MAP increased to a greater extent in L-NAME rats than in C rats (21±4 vs 8±0.3 mmHg). Thus, blockade of EDNO synthesis significantly enhanced the chronic hypertensive effects of insulin in rats. These observations suggest that EDNO may help to minimize the rise in blood pressure during chronic hyperinsulinemia in rats. (Supported by HL51971, HL39399, and HL23502).

AB - We have previously shown that chronic hypcrinsulinemia causes hypertension in rats and acute studies suggest that endothelial-derived nitric oxide (EDNO) may modulate the vascular actions of insulin. The present study was designed to determine whether blockade of EDNO synthesis with nitro-L-arginine methyl ester (L-NAME) exacerbates the hypertensive actions of insulin in conscious rats. Male Sprague-Dawley rats were instrumented with arterial and venous catheters and mean arterial pressure (MAP) was monitored continuously 24 hr/day. After 7 days of control measurments, rats were given either vehicle (C rats, n=4) or L-NAME (10 μg/kg/min, i.V., n=4) throughout the entire experiment After 4 days of L-NAME or vehicle infusion, a 5 day infusion of insulin (1.5 mU/kg/min, i.v.) was initiated while euglycemia was maintained with glucose infusion (22 mg/kg/min, i.v.). After 4 days of L-NAME infusion, MAP increased from 91±1 to 122±2 mmHg. Vehicle infusion did not significantly alter MAP in C rats. After 5 days of insulin infusion, MAP increased to a greater extent in L-NAME rats than in C rats (21±4 vs 8±0.3 mmHg). Thus, blockade of EDNO synthesis significantly enhanced the chronic hypertensive effects of insulin in rats. These observations suggest that EDNO may help to minimize the rise in blood pressure during chronic hyperinsulinemia in rats. (Supported by HL51971, HL39399, and HL23502).

UR - http://www.scopus.com/inward/record.url?scp=26144436905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26144436905&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:26144436905

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -